| Dependent variable | |||||||
---|---|---|---|---|---|---|---|---|
Days used | Penn total | SD work | SD Social life | SD family | CGI | HAM-A | HAM-D | |
Time period (reference: baseline; type III SS p-value) | 0.007 | < 0.001 | 0.011 | < 0.001 | < 0.001 | 0.001 | 0.002 | < 0.001 |
 6 week follow-up | − 3.223*** (1.043) | − 9.070*** (1.908) | − 2.590** (1.050) | − 4.060*** (1.009) | − 3.383*** (0.978) | − 1.013** (0.415) | − 3.332* (1.953) | − 2.444* (1.333) |
 3 month follow-up | − 2.318** (0.982) | − 12.545*** (1.785) | − 2.761*** (0.982) | − 5.580*** (0.948) | − 5.322*** (0.912) | − 1.631*** (0.396) | − 6.770*** (1.850) | − 6.073*** (1.288) |
Treatment group (reference: control; type III SS p-value) | 0.256 | 0.297 | 0.152 | 0.990 | 0.918 | 0.900 | 0.720 | 0.856 |
 Intervention | 1.342 (1.163) | − 2.533 (2.392) | 1.652 (1.128) | − 0.013 1.015) | − 0.114 (1.106) | − 0.060 (0.456) | − 1.009 (2.792) | 0.305 (1.666) |
Age at baseline (type III SS p-value) | 0.866 | 0.899 | 0.834 | 0.972 | 0.527 | 0.874 | 0.105 | 0.021 |
 | 0.010 (0.056) | 0.016 (0.126) | − 0.011(0.052) | − 0.002 (0.043) | − 0.035 (0.055) | − 0.003 (0.021) | 0.265 (0.159) | 0.212** (0.088) |
CGI-severity at baseline (type III SS p-value) | 0.060 | 0.455 | 0.321 | 0.418 | 0.924 | N/A | 0.067 | 0.139 |
 | 0.924* (0.476) | − 1.002 (1.325) | − 0.564 (0.560) | − 0.377 (0.459) | − 0.056 (0.581) |  | 3.163* (1.671) | 1.411 (0.932) |
Number of days in past 2 weeks using meth at baseline (ttype III SS p-value) | N/A | 0.991 | 0.173 | 0.050 | 0.138 | 0.009 | 0.564 | 0.925 |
 |  | − 0.003 (0.280) | 0.167 (0.120) | 0.201** (0.099) | 0.188 (0.124) | 0.107*** (0.039) | 0.205 (0.353) | − 0.019 (0.198) |
Time period by treatment group interaction (reference: baseline control; type III SS p-value) | 0.002 | 0.230 | 0.531 | 0.753 | 0.948 | 0.171 | 0.049 | 0.660 |
 6 week follow-up Intervention | − 4.783*** (1.550) | 2.041 (2.833) | − 0.603 (1.543) | − 0.249 (1.483) | 0.128 (1.436) | − 1.123* (0.624) | − 5.460* (2.937) | − 1.817 (2.005) |
 3 month follow-up Intervention | − 4.626*** (1.463) | 4.601* (2.661) | − 1.628 (1.453) | 0.802 (1.403) | 0.433 (1.349) | − 0.813 (0.586) | − 6.452** (2.732) | − 0.594 (1.886) |
Constant | 3.232 (3.134) | 27.087*** (7.127) | 7.266** (2.999) | 7.905*** (2.466) | 8.033** (3.103) | 4.353*** (0.815) | − 6.052 (8.957) | (4.983) − 1.249 |
Observations | 113 | 113 | 111 | 111 | 111 | 111 | 111 | 110 |
Log Likelihood | − 297.348 | − 367.367 | − 289.208 | − 280.067 | − 285.397 | − 196.906 | − 369.688 | − 320.790 |
Akaike Inf. Crit. | 614.695 | 756.734 | 600.417 | 582.133 | 592.794 | 413.812 | 761.376 | 663.580 |
Bayesian Inf. Crit. | 641.235 | 785.822 | 629.292 | 611.008 | 621.668 | 440.160 | 790.251 | 692.346 |